Following FDA approval of the AspireSR® generator for the VNS Therapy® system in June 2015, more than a thousand patients with drug-resistant epilepsy across the United States have received this new treatment option. Many of these patients are experiencing benefits which have positively impacted their lives – and are sharing their stories during Epilepsy Awareness Month with the hope of encouraging others to seek new treatments for drug-resistant epilepsy. Numerous hospitals nationwide have begun providing the AspireSR device to patients with drug-resistant epilepsy – a condition that affects as many as one-third of people with epilepsy, causing them to have seizures in spite of treatment with antiepileptic medications.
The VNS Therapy system is a minimally invasive option in which a medical device is placed under the skin in the upper chest area during an outpatient procedure. The device sends mild electrical pulses through the vagus nerve to areas of the brain known to be associated with seizures. The new AspireSR generator takes the VNS Therapy technology a step further – detecting relative heart-rate increases that are often associated with seizures in people with epilepsy and providing responsive stimulation in an attempt to stop and shorten seizures and improve recovery.
To view the multimedia release go to:
http://www.multivu.com/players/English/7651751-livanova-aspiresr-treatment/
BLACK+DECKER™ announces new powered kitchen and bathroom scrubbers for cleaning without all the work. The GrimeBuster™, GrimeBuster™ Pro, and ScumBuster® Pro motorize scrubbing in order to agitate surface materials, eliminating the typical “elbow grease” that manual cleaning requires.
The GrimeBuster™ ($14.99 MSRP) and GrimeBuster™ Pro ($29.99 MSRP) quickly clean kitchen surfaces, dirty pots and pans, sinks, microwaves, and more. They are lightweight and each feature an ergonomic design. With a slip-resistant grip, they are also submersible in water. Each scrubber comes with two dishwasher-safe scrubbing attachments – one with a non-scratch sponge and one with nylon bristles. Heavy-duty sponge and bristle brush attachments will be sold separately. The GrimeBuster™ is powered by four included alkaline batteries. The GrimeBuster™ Pro has added features, including a longer handle and a charging dock that powers its long-lasting Lithium-Ion battery. The attractively designed GrimeBuster™ Pro can be left on the counter on its charging base until it’s time to clean again.
To view the multimedia release go to:
https://www.multivu.com/players/English/8005955-black-decker-powered-scrubbers/
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
At more than 60 percent quieter1, 30 percent lighter and 45 percent more compact than a standard generator2, the new Briggs & Stratton Q6500 QuietPower™ Series inverter generator3 introduces category-changing innovations to the generator market. Its fully-enclosed, impact-resistant shell significantly reduces noise and its lightweight compact design answers unmet needs among generator owners.
“We created a residential backup power source that drew upon the convenience and fuel efficiency inverters have brought to camping and tailgating events, but also increased the power output and value to serve the portable home backup market,” says Dan Roche, director of marketing, portable power and cleaning systems at Briggs & Stratton. “The Q6500 combines the best of inverter technology with enough wattage for total home power restoration.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8083851-briggs-stratton-q6500-quietpower-series-inverter-generator/
Honeywell (NYSE: HON) announced today that the same Spectra® fiber technology used in protective vests for law enforcement is now available to shield the belongings of everyday consumers from thieves who slash bags to steal items.
Consumers who want to keep their belongings safe can now buy a theft-resistant drawstring backpack called the Flak Sack, designed by Loctote Industrial Bag Company. As seen on ABC’s “Shark Tank,” the Flak Sack is the world’s first cut-resistant bag designed for travel and daily use. Now, it will be enhanced with Spectra—the same fiber technology used in bullet-resistant vests. Flak Sack utilizes Spectra in a unique fabric construction called FLAKnit™ created by Tuff-N-Lite®, a division of Supreme Corp., a leading textile and fiber technology company. Yet, despite this durability, Flak Sack is flexible, making it ideal for a range of situations such as travel, hiking and everyday use such as commuting to work.
To view the multimedia release go to:
https://www.multivu.com/players/English/8083951-honeywell-spectra-fiber-flak-sack-cut-resistant-bag/
A ten-month clinical trial at Sentara Leigh Hospital in Norfolk, Virginia has determined that hard surfaces and linens infused with copper oxide compounds contributed to an 83% reduction in C-difficile and a 78% overall reduction in a host of multi-drug resistant organisms (MDROs) including C-diff, MRSA and VRE in a real-world clinical environment. These results occurred in a hospital with a robust protocol for managing infection risk certified by the health care accrediting body DNV-GL Healthcare.
The results of the trial were published in the peer-reviewed American Journal of Infection Control on Sept. 28, 2016 and will be presented at the annual conference of the Infectious Disease Society of America in New Orleans, Louisiana on October 27, 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7955751-sentara-healthcare-infections-copper-clinical-trial/
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
Q&Q SmileSolar, known for its fun, color-driven and eco-friendly watches, unveils a digital campaign video filmed and animated by Cait Davis of Springtime Jellyfish. The video brings the brand’s core values to life in a fresh, modern way. Watches are available to purchase via the brand’s online store at store.smile-qq.com.
The Q&Q SmileSolar hero video highlights two of the brand’s most popular styles – the 20 Bar ($60 retail) and Mini ($40 retail) - that are completely solar-powered, keeping them operating up to approximately three-and-a-half months after one single charge. The watches are also all eco-friendly – the strap and case incorporate recycled materials – and each have a durable water-resistant casing as well.
The video also gives nod to the brand’s commitment to Table for Two, a non-profit that delivers school meals to children in Africa and Asia. A percentage of sales from each watch goes to support the cause. To date, Q&Q has donated over 131,000 meals.
To view the multimedia release go to:
https://www.multivu.com/players/English/7886551-q-and-q-smilesolar-hero-video
Sally Hansen continues to lead in innovation by introducing its new Color Therapy products: a nail polish, top coat, and nail & cuticle oil, inspired by women’s desire to wear beautiful color while simultaneously caring for their nails. Sally Hansen’s Color Therapy nail polish contains a patented micro-delivery system that delivers an argan oil-enriched formula, resulting in intensive nourishment and instant moisture for healthier-looking nails. The Color Therapy nail polish needs no base coat so the oil complex can directly contact the bare nail. 9 out of 10 women experienced a noticeable improvement in their natural nails after wearing the Color Therapy nail polish. Vibrant tones, available in three magnificent palettes, glide on for a radiant, shiny finish with up to 10 days of fade-proof, chip-resistant wear. The Color Therapy nail polish provides the ultimate color that cares while you wear, with everything needed to restore nails without sacrificing luminous color.
Complete your manicure with the Color Therapy top coat and nail & cuticle oil, both formulated with the same argan oil contained in the nail polish. The top coat provides an ultra-glossy finish for extended wear, and the nail & cuticle oil, the ultimate in nail therapy, instantly makes nails and cuticles look healthier, restored, and rejuvenated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7957151-sally-hansen-color-therapy-nail-polish/
MAKE UP FOR EVER, the professional makeup line of innovative and artistic products created for professional stage artists, makeup artists and makeup enthusiasts, announces a worldwide artistic collaboration with global pop sensation CHARLI XCX and reveals its new AQUA XL EYE PENCIL campaign.
CHARLI XCX’s bold, artistic and energetic stage presence exemplifies the creative spirit of MAKE UP FOR EVER and the performance of the AQUA XL collection. In 2016, MAKE UP FOR EVER joins CHARLI XCX in all her performances and artistic creations, from her live tour to makeup artistry for her video clips. A virtuoso of words and sound, CHARLI XCX has written several international hit songs including her double platinum single, “Boom Clap,” alongside co-penning music for renowned artists; Grammy nominated “Fancy” (Iggy Azalea), triple platinum selling “I Love It” (Icona Pop) and “Same Old Love” (Selena Gomez).
The AQUA line, upon which performers and their makeup artists have long relied, has become AQUA XL, taking the limits of makeup performance to new levels. MAKE UP FOR EVER is revamping one of its iconic products with a new high-performance formula: AQUA XL EYE PENCIL, the first of the AQUA XL line and specially designed for performers’ needs. AQUA XL EYE PENCIL are stage-proof and offer flawless makeup results, incredible stay-on power and high color intensity. As comfortable as it is easy to apply, the AQUA XL EYE PENCIL’s long wear waterproof formula is resistant to all stage conditions and perfect for real life-use.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7792251-make-up-for-ever-teams-up-with-charli-xcx/
Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best.
Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
